The founder and former CEO of New Hampshire’s largest network of addiction treatment centers has been charged with ...

A drug that once showed promise as a treatment for alcohol use disorder did not work as expected, a new UCLA clinical trial ...

A new treatment nearly halves the risk of disease progression or death from a less common form of breast cancer that hasn't ...

The pharma giant is betting that Blueprint, whose research revolves around a certain kind of tyrosine kinase, will be a boost ...

In an initial trial, patients who suffer from chronic nerve pain got relief from an interactive game that trained them to ...

Nucala's approval offers hope for uncontrolled COPD. This new drug reduces flare-ups, a key benefit for Black Americans.

The value of the combination of albuterol/budesonide is high due to its alleviating of corticosteroid burden, according to Reynold Panettieri Jr, MD.

The company also stated that the interim data from the trial showed the therapy significantly extended median overall ...

Creon, a pancreatic enzyme replacement therapy, helps patients with pancreatic cancer and cystic fibrosis digest food. Its ...

Hovanesian: There are a whole host of drugs that are pursuing complement inhibition, and then other classes of drugs as well that promise to address GA and it’s hard to tell which will be most ...